ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Development of ligand modified erythrocyte coated polydopamine nanomedicine to codeliver chemotherapeutic agent and oxygen for chemo-photothermal synergistic cancer therapy

Zhang, Liyao; Huang, Peijie; Huang, Shubin; Wang, Tao; Chen, Shufeng; Chen, Zhihao; Zhou, Yi*; Qin, Linghao*广东药学院; 广州医学院; y
International Journal of Pharmaceutics2022-10-15DOI: 10.1016/j.ijpharm.2022.122156
4被引5阅读
引用收藏
分享

摘要

The use of conventional chemotherapy often faces limitations such as severe side effects, weak tumor tissue specificity, and the development of multidrug resistance. To conquer these challenges, numerous novel drug carriers have been designed in recent years. However, due to the complex processes of tumor development, metastasis and recurrence, single chemotherapy cannot fulfill the goals of clinical diverse treatment. In this work, by utilizing the inherent characteristics of surface-modified erythrocyte and the outstanding photothermal conversion capability of polydopamine (PDA), we designed and constructed a biomimetic multifunctional nanomedicine DPPR NPs to codeliver chemotherapeutic agent doxorubicin (DOX) and oxygen. The results showed that DPPR NPs exhibited inspiring features including nanoscale droplet size, good physicochemical stability, and sustained, pH-, and NIR triggered drug release behavior. It can dramatically prolong the systematic circulation time and elevated the drug accumulated level in the tumor site. Moreover, DPPR NPs could be effectively internalized into tumor cells and destroyed the intracellular redox balance to mediate cell apoptosis. It exerted excellent in vivo tumor targeting effect, photothermal conversion efficiency, ultrasound imaging re-sponses, antitumor efficacy, and good compatibility. In summary, DPPR NPs provide a biomimetic drug delivery platform to organically combine chemotherapy and photothermal therapy for precise cancer treatment.

学科与关键词

关键词
ErythrocyteDoxorubicinPolydopamineOxygenChemotherapyPhotothermal therapy
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
International Journal of Pharmaceutics
发表日期
2022-10-15
卷期
第 626 卷
页码
122156
DOI
10.1016/j.ijpharm.2022.122156
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Science and Technology Program of Guangzhou [201604046022, 201802030002]; Project of Guangdong Provincial Department of Education [2022ZDZX2034]

作者

  • Z

    Zhang, Liyao (第一作者)

    guangdong pharmaceut univ

  • H

    Huang, Peijie

    guangdong pharmaceut univ

查看全部 8 位作者收起作者
  • H

    Huang, Shubin

    guangdong pharmaceut univ

  • W

    Wang, Tao

    changzhi med coll

  • C

    Chen, Shufeng

    guangdong pharmaceut univ

  • C

    Chen, Zhihao

    guangdong pharmaceut univ

  • Z

    Zhou, Yi (通讯)

    guangzhou med univ

  • Q

    Qin, Linghao (通讯)

    guangdong pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417